Recombinant humanized type III collagen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant humanized type III collagen, covering 2024-12-10 to 2024-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Impact of Recombinant Humanized Type III Collagen on the Immediate and Long-term Effects of Breast Tumor Surgery [Phase 1]